Obermatt

Solasto

TYO:6197 · JP3436250009
Health Care Providers & ServicesMedium

360

59
EV / EBIT54
Price / Owner Earnings36
Owner Earnings Yield82
Dividend Yield59
Price/Sales77
EV / Gross Profit52
Price/Book22
Return on Capital88
Cash Return on Capital96
Return on Equity84
EBIT Margin54
Gross Profitability61
Cash Conversion40
Accruals49
Owner Earnings Margin63
Sales growth20
Profit Growth27
Long-Term EPS Growth15
Owner Earnings Growth39
Reinvestment67
Price momentum100
Debt load22
Refinancing34
Debt Payback62
Liquidity72
Analyst ratings20
Opinion Changes50
Price Target Upside1
Market mood1
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Solasto clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryJapan
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeTSE
Founded1968
Employees3
ISINJP3436250009
Last UpdateApr 2, 2026
Index & Theme
Outpatient CareAssisted LivingEducationMedicalProfessional Services

Description

Analysis

Middle-of-the-road

Solasto Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is attractive. The owner-earnings multiple stands at 14.4×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is sturdy. The company scores 12/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
10
2023202420252026

All-time high

93

Jan 2025

All-time low

8

Mar 2026

Average rank

47

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
77
88
89
80
Price/Earnings
35
81
93
47
Price/Book
22
58
62
31
Dividend Yield
59
88
78
78
Value (overall)
39
91
92
55

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Solasto with its peers
AS ONE
TYO:7476
80
CountryJapan
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
BML
TYO:4694
74
CountryJapan
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Pro Medicus
ASX:PME
67
CountryAustralia
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →
Daiichi Sankyo
TYO:4568
56
CountryJapan
IndustryPharmaceuticals
SizeX-Large
Full Stock Analysis →
H.U. Group Holdings
TYO:4544
83
CountryJapan
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Oceania Healthcare
NZC:OCA
17
CountryNew Zealand
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →